Qiagen N.V. - ADR Peer Comparison

$43.39

$0.10 (0.23%)

As on 01-Sep-2026 16:00EDT

Market cap

$9,272 Mln

Revenue (TTM)

$2,100 Mln

P/E Ratio

22.7

P/B Ratio

2.7

Div. Yield

0.8 %

Edit

	Qiagen N.V. - ADR	Pharvaris BV (PHVS)	Uniqure NV (QURE)	ProQR Therapeutics N.V. - ADR	ATAI Life Sciences BV (ATAI)
Market cap ($ Mln)	9,272	2,480	3,380	323	2,704
Revenue ($ Mln)	2,100	--	19	19	4
Net Profit ($ Mln)	409.32	-171.57	-252.21	-42.32	-668.19
Net Margin (%)	19.49	--	-1,350.73	-228.38	-14,938.37
RoE (%)	11.47	-59.98	-96.46	-65.71	-335.54
Price to Earnings	22.68	--	--	--	--
Price-To-Book	2.74	7.40	10.60	3.51	15.46

Cashflow ($ Mln)

	Qiagen N.V. - ADR	Pharvaris BV (PHVS)	Uniqure NV (QURE)	ProQR Therapeutics N.V. - ADR	ATAI Life Sciences BV (ATAI)
Cash From Operating Activities	654.33	-137.07	-177.96	-52.79	-102.68
Cash Flow from Investing Activities	-305.28	-0.16	-321.62	-1.02	-109.13
Cash from Financing Activities	-178.98	160.61	415.40	-1.84	269.48
Net Cash Inflow / Outflow	--	--	--	--	--

	Qiagen N.V. - ADR	Pharvaris BV (PHVS)	Uniqure NV (QURE)	ProQR Therapeutics N.V. - ADR	ATAI Life Sciences BV (ATAI)
ROCE (%)	8.01	-64.99	-50.07	-44.48	-361.72
ROE (%)	11.47	-59.98	-96.46	-65.71	-335.54
ROA (%)	6.10	-38.54	-29.77	-17.96	-184.51
EBIT Margin (%)	23.80	--	-1,047.15	-229.99	-15,198.77
Net Margin (%)	19.49	--	-1,350.73	-228.38	-14,938.37
Cash Profit Margin (%)	0.00	--	0.00	0.00	-0.02

	Qiagen N.V. - ADR	Pharvaris BV (PHVS)	Uniqure NV (QURE)	ProQR Therapeutics N.V. - ADR	ATAI Life Sciences BV (ATAI)
Revenue Growth (%)	2.96	--	30.24	12.40	93.72
EBIT Growth (%)	-4.99	1.05	-44.77	-13.38	-530.01
Net Profit Growth (%)	9.62	-1.94	-26.74	-6.67	-459.61
EPS Growth (%)	14.23	15.07	-4.52	6.83	-316.60
Book Value Growth (%)	0.56	31.10	6,797.66	-3.20	-33.14

	Qiagen N.V. - ADR	Pharvaris BV (PHVS)	Uniqure NV (QURE)	ProQR Therapeutics N.V. - ADR	ATAI Life Sciences BV (ATAI)
Price / Earnings	21.99	-10.30	-6.92	-5.14	-1.38
Price / Book Value	2.47	6.67	6.92	3.59	4.09
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	13.80	-8.76	-11.07	-3.13	-0.99
Market Cap ($ Cr)	--	--	--	--	--

	Qiagen N.V. - ADR	Pharvaris BV (PHVS)	Uniqure NV (QURE)	ProQR Therapeutics N.V. - ADR	ATAI Life Sciences BV (ATAI)
Debt to Equity	0.48	0.00	0.15	0.00	0.00
Short term debt to equity ratio	0.00	0.00	0.01	0.06	0.02
Current Ratio	2.85	11.94	10.01	3.49	8.58
Quick Ratio	2.31	11.94	10.01	3.49	8.58
Interest Coverage	12.71	-1,045.90	-3.11	-45.75	-334,090.00

	Qiagen N.V. - ADR	Pharvaris BV (PHVS)	Uniqure NV (QURE)	ProQR Therapeutics N.V. - ADR	ATAI Life Sciences BV (ATAI)
Debtors to sales (%)	19.00	--	30.94	10.03	14.46
Asset Turnover	0.31	0.00	0.02	0.08	0.01
Receivable days	75.29	--	133.23	96.49	704.55
Inventory Days	132.91	--	0.00	--	--
Payable days	35.66	--	1,342.82	25.78	1,357.42
Cash Conversion Cycle	172.54	--	-1,209.59	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.